Bayer Announces Primary Endpoint Achieved in Phase III FINEARTS-HF Cardiovascular …
“Bayer is determined to drive research and innovations that have the potential to become treatment options for diseases with high unmet medical need, …
“Bayer is determined to drive research and innovations that have the potential to become treatment options for diseases with high unmet medical need, …